Picture of Emyria logo

EMD Emyria Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+13.61%
3m-12.77%
6m-14.79%
1yr+49.58%
Volume Change (%)
10d/3m+31.44%
Price vs... (%)
52w High-49.5%
50d MA+20.62%
200d MA-15.56%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-62.24%
Return on Equity-86.57%
Operating Margin-403.17%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Emyria EPS forecast chart

Profile Summary

Emyria Limited is an Australia-based company, which develops biopharmaceuticals guided by real-world data collected with patients across its clinical service subsidiary, Emerald Clinics. The Company is staffed and managed by medical practitioners, including Specialists and General Practitioners. The Company operates seven clinical sites around Australia. Patient appointments can be made in clinic or via Telehealth once a referral is received. It has seen approximately 5000 patients with over 40 clinical indications for patients between the ages of 2-96 years. The Company’s clinician-led care teams provide personalized, evidence-generating care for patients with unmet needs. The Company monitors and evaluates new treatments while generating insights that help it provide individualized care. It treats approximately 44 different debilitating and health concerns, including mental health, chronic pain, addiction, neurodegenerative, gastrointestinal and musculoskeletal conditions.

Directors

Last Annual
June 30th, 2021
Last Interim
December 31st, 2021
Incorporated
March 19th, 2018
Public Since
February 12th, 2020
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
274,963,253
Blurred out image of a map
Address
North Perth, PERTH, 6906
Web
https://www.emeraldclinics.com.au/
Phone
+61 300436363
Auditors
Stantons International Audit and Consulting PTY Ltd

EMD Share Price Performance

Upcoming Events for EMD

Full Year 2022 Emyria Ltd Earnings Release

Emyria Ltd Annual Shareholders Meeting

Similar to EMD

Picture of Althea group logo

Althea group

au flag iconAustralian Stock Exchange - SEATS

Picture of Apiam Animal Health logo

Apiam Animal Health

au flag iconAustralian Stock Exchange - SEATS

Picture of Artrya logo

Artrya

au flag iconAustralian Stock Exchange - SEATS

Picture of Asian American Medical logo

Asian American Medical

au flag iconAustralian Stock Exchange - SEATS

Picture of Australian Clinical Labs logo

Australian Clinical Labs

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email